Top Markets
#1 Resolv wstUSR Resolv wstUSR +114.61%
#2 Luxxcoin Luxxcoin +45.15%
#3 ResearchCoin ResearchCoin +21.62%
#4 Reactive Network Reactive Network +21.45%
#5 Layer3 Layer3 +19.67%
#6 Orderly Network Orderly Network +16.55%
#7 Aria.AI Aria.AI +12.61%
#8 Bitgert Bitgert +11.76%
#9 Lisk Bridged wstETH (Lisk) Lisk Bridged wstETH (Lisk) +9.32%
#10 KAITO KAITO +9.04%
Coin of the day
Resolv wstUSR Resolv wstUSR
Tetapan
Bahasa
MALAY
Mata wang
USD
Tema
CSL Limited CSL Limited

CSL Limited

CSL
Kedudukan dalam Saham #432
CSL Limited researches, develops, manufactures, markets, and distributes... CSL Limited researches, develops, manufactures, markets, and distributes biopharmaceutical and allied products in Australia, the United States, Germany, the United Kingdom, Switzerland, China, and internationally. The company operates through two segments, CSL Behring and CSL Seqirus. The CSL Behring segment offers plasma therapies, such as plasma products and recombinants. This segment also conducts research on plasma and non-plasma therapies; and receives license and royalty from the commercialization of intellectual property. The CSL Seqirus segment manufactures and distributes non-plasma biotherapeutic products; and develops influenza related products. CSL Limited was founded in 1916 and is headquartered in Parkville, Australia.
Harga Saham
$99.32
Modal Pasaran
$48.20B
Perubahan (1 hari)
0.98%
Perubahan (1 tahun)
-32.14%
Negara
AU
Perdagangan CSL Limited (CSL)

Kategori

Healthcare
Nisbah P/S bagi CSL Limited (CSL)
Nisbah P/S pada April 2026 TTM: 3.04
Menurut laporan kewangan dan harga saham terkini CSL Limited, nisbah P/S semasa (TTM) ialah 3.04. Pada akhir 2024, nisbah P/S syarikat ialah 6.41.
Sejarah nisbah P/S untuk CSL Limited dari 2000 hingga 2026
Nisbah P/S pada akhir setiap tahun
Tahun Nisbah P/S Ubah
2026 (TTM) 3.04 -38.45%
2025 4.94 -22.88%
2024 6.41 -5.17%
2023 6.76 -18.55%
2022 8.30 -11.89%
2021 9.41 -32.01%
2020 13.85 68.62%
2019 8.21 -5.05%
2018 8.65 -3.44%
2017 8.96 40.54%
2016 6.37 10.70%
2015 5.76 -10.38%
2014 6.42 5.17%
2013 6.11 32.22%
2012 4.62 7.93%
2011 4.28 4.43%
2010 4.10 -0.89%
2009 4.14 -28.34%
2008 5.77 13.98%
2007 5.06 47.22%
2006 3.44 43.15%
2005 2.40 -30.03%
2004 3.43 131.43%
2003 1.48 -77.36%
2002 6.55 -22.18%
2001 8.42 0.00%
2000 0.00 0.00%
Nisbah P/S untuk syarikat atau pesaing yang serupa
Syarikat Nisbah P/S Perbezaan Nisbah P/S Negara
Novo Nordisk A/S Novo Nordisk A/S
Novo Nordisk A/S
NVO.US
3.32 9.17%
DK
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
9.42 209.87%
US
Regeneron Pharmaceuticals, Inc. Regeneron Pharmaceuticals, Inc.
Regeneron Pharmaceuticals, Inc.
REGN.US
5.60 84.08%
US
UCB SA UCB SA
UCB SA
UCB.BR
6.36 109.07%
BE
Argenx SE Argenx SE
Argenx SE
ARGX.US
13.15 332.61%
NL